J1096 HCPCS code: Dexamethasone, lacrimal ophthalmic insert, 0.1 mg
J1096 is the HCPCS Level II code for dexamethasone, lacrimal ophthalmic insert, 0.1 mg. In 2024 Medicare paid an average of $92.89 per service for J1096 across 359,190 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 8 per day on outpatient hospital claims. Medicare volume rose 38% from 2022 to 2024 (260,177 to 359,190 services). In 2024, about 464 clinicians billed Medicare for J1096 for 54,881 beneficiaries; New Jersey, Arizona, Florida accounted for 31% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2019-10-01 |
| Last action effective | 2019-10-01 |
Who bills J1096 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 464 |
| Medicare beneficiaries | 54,881 |
| States with claims | 38 |
| Share of services in top 3 states (New Jersey, Arizona, Florida) | 31% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1096, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 260,177 | 40,844 | $131.04 | $104.52 |
| 2023 | 325,418 | 50,404 | $124.74 | $99.47 |
| 2024 | 359,190 | 54,881 | $116.60 | $92.89 |
States with the most J1096 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| New Jersey | 40,870 | $92.11 |
| Arizona | 38,941 | $92.33 |
| Florida | 31,853 | $95.09 |
| Virginia | 31,300 | $92.14 |
| New York | 20,393 | $93.13 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 8 | Anatomic Consideration |
| practitioner claims | 8 | Anatomic Consideration |
What changed for J1096
- 2019-10-01: J1096 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1096?
J1096 is the HCPCS Level II code for dexamethasone, lacrimal ophthalmic insert, 0.1 mg. Short descriptor: "Dexametha opth insert 0.1 mg".
How much does Medicare pay for J1096?
In 2024, the average Medicare payment was $92.89 per service (average allowed $116.60).
Does Medicare cover J1096?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J1096 can be billed per day?
8 on outpatient hospital claims; 8 on practitioner claims (NCCI medically unlikely edits).
Related J10 codes
- J1000 — Injection, depo-estradiol cypionate, up to 5 mg
- J1010 — Injection, methylprednisolone acetate, 1 mg
- J1020 — Injection, methylprednisolone acetate, 20 mg
- J1030 — Injection, methylprednisolone acetate, 40 mg
- J1040 — Injection, methylprednisolone acetate, 80 mg
- J1050 — Injection, medroxyprogesterone acetate, 1 mg
- J1060 — Injection, testosterone cypionate and estradiol cypionate, up to 1 ml
- J1070 — Injection, testosterone cypionate, up to 100 mg
- J1071 — Injection, testosterone cypionate, 1 mg
- J1072 — Injection, testosterone cypionate (azmiro), 1 mg
- J1073 — Testosterone pellet, implant, 75 mg
- J1080 — Injection, testosterone cypionate, 1 cc, 200 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1096
- Watch J1096 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1096
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.